Adverse Effects of Aromatase Inhibition on the Brain and Behavior in a Nonhuman Primate

Nicole J. Gervais, Luke Remage-Healey, Joseph R. Starrett, Daniel J. Pollak, Jessica A. Mong, Agnès Lacreuse

Research output: Contribution to journalArticleAcademicpeer-review

40 Citations (Scopus)

Abstract

Breast cancer patients using aromatase inhibitors (AIs) as an adjuvant therapy often report side effects, including hot flashes, mood changes, and cognitive impairment. Despite long-term use in humans, little is known about the effects of continuous AI administration on the brain and cognition. We used a primate model of human cognitive aging, the common marmoset, to examine the effects of a 4-week daily administration of the AI letrozole (20 μg, p.o.) on cognition, anxiety, thermoregulation, brain estrogen content, and hippocampal pyramidal cell physiology. Letrozole treatment was administered to both male and female marmosets and reduced peripheral levels of estradiol (E2), but unexpectedly increased E2 levels in the hippocampus. Spatial working memory and intrinsic excitability of hippocampal neurons were negatively affected by the treatment possibly due to increased hippocampal E2. While no changes in hypothalamic E2 were observed, thermoregulation was disrupted by letrozole in females only, indicating some impact on hypothalamic activity. These findings suggest adverse effects of AIs on the primate brain and call for new therapies that effectively prevent breast cancer recurrence while minimizing side effects that further compromise quality of life.
Original languageEnglish
Pages (from-to)918-928
JournalThe Journal of Neuroscience
Volume39
Issue number5
DOIs
Publication statusPublished - 30-Jan-2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Adverse Effects of Aromatase Inhibition on the Brain and Behavior in a Nonhuman Primate'. Together they form a unique fingerprint.

Cite this